An attempt has been made in this study to present an overview of the patenting intensity of South Asian Association for Regional Cooperation (SAARC) countries. Patent data originating from SAARC countries from 1995 to 2011, filed through World Intellectual Property Organization (WIPO), European Patent Office and United States Patent and Trademark Office were collected and analysed.
Every geographical region has its name and fame. Mostly the qualities and characteristics of certain goods attributable to some geographical locations and reputable to “as produce of certain region” come under
Geographical Indications (GI). It is an emerging trend in Intellectual Property Rights. This review provides an overview of the past and current scenario of Geographical Indications in India with its challenges. It also
Despite large gains in health over the past few decades, the distribution of health risks worldwide remains extremely and unacceptably uneven says the Lancet–University of Oslo Commission on Global Governance for Health.
The Indian pharmaceutical company has been built from an industry that copies patent drugs and manufactures them inexpensively. Now it is counted amongst the industries that are fuelling India‘s economic growth and holds enormous potential. Indian-based pharmaceutical companies are also predicted to gain considerable market share in the world. It ranks third world wide, in terms of technology, quality and range of medicines manufactured. Indian Pharma Company fulfils around 70 percent of the country‘s demand all together.
As the effective application of new technologies has become increasingly important to most nations’ economic growth and development, the significance of intellectual property (IP) rights has also increased.
Industrialised countries should phase out HFC says Sunita Narain, Director-General, CSE in this presentation at CSE Annual South Asian Media Briefing Workshop on Climate Change, 2013 held from September 18-19, 2013.
Judgement of the Supreme Court of India in the matter of Commissioner of Central Excise, Thane-II Vs M/s. Time Pharma, Mumbai dated 14/08/2013 regarding pharmaceutical products for the purposes of Central Excise tariff.